Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Merck & Co., Inc. (MRK) had Consolidated Net Income/Loss of $377.00M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
$60.12B |
|
$365.00M |
|
$16.13B |
|
$43.99B |
|
$57.16B |
|
$2.95B |
|
$-1.06B |
|
$1.89B |
|
$2.49B |
|
$377.00M |
|
$377.00M |
|
Consolidated Net Income/Loss |
$377.00M |
$1.46B |
|
$2.95B |
|
$6.83B |
|
2.54B |
|
2.55B |
|
$0.14 |
|
$0.14 |
|
Balance Sheet Financials | |
$32.17B |
|
$23.05B |
|
$74.51B |
|
$106.67B |
|
$25.69B |
|
$33.68B |
|
$43.35B |
|
$69.04B |
|
$37.63B |
|
$-1.57B |
|
$37.63B |
|
2.53B |
|
Cash Flow Statement Financials | |
$13.01B |
|
$-14.08B |
|
$-4.81B |
|
$12.77B |
|
$6.91B |
|
$-5.86B |
|
$645.00M |
|
$-7.45B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.25 |
|
-- |
|
-- |
|
0.47 |
|
0.93 |
|
73.17% |
|
4.91% |
|
4.91% |
|
11.35% |
|
3.14% |
|
0.61% |
|
$9.14B |
|
-- |
|
-- |
|
-- |
|
0.56 |
|
2.54 |
|
5.81 |
|
62.84 |
|
1.00% |
|
-23.97% |
|
0.35% |
|
0.53% |
|
$14.87 |
|
$3.59 |
|
$5.11 |